Clinical trial
Efficacy and Safety of Daclatasvir Plus Asunaprevir Treatment in Patients With Chronic Hepatitis C : Prospective Cohort Study
NCT02639585 is registered in ClinicalTrials.gov with Pusan National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Daclatasvir Plus Asunaprevir Treatment in Patients With Chronic Hepatitis C : Prospective Cohort Study
- Lead sponsor
- Pusan National University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- June 30, 2017
- Enrollment
- 32 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.